CLASS III Drug recall · Reported 17 Feb 2016 · FDA Enforcement Report

Candesartan Cilexetil Tablets, 16 mg (5 x, Rx recalled

Amerisource Health Services is recalling Candesartan Cilexetil Tablets, 16 mg (5 x, Rx, distributed nationwide in the US. The recall was initiated on 26 Jan 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # 153855, exp 01/2017
Quantity recalled716 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0660-2016
FDA event ID
73166
Recalling firm
Amerisource Health Services, Columbus, OH
Classification
Class III
Status
Terminated
Recall initiated
26 Jan 2016
FDA classified
11 Feb 2016
Reported
17 Feb 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

26 Jan 2016Recall initiated by company
11 Feb 2016Classified by FDA+16 days
17 Feb 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications; 9 month stability (manufacturer)

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Candesartan Cilexetil Tablets, 16 mg, 30 Tablets (5 x 6) blister pack, Rx, Distributed by: American Health Packaging Columbus, Ohio 43217, NDC 68084-877-25(carton), NDC 68084-877-95(individual dose)

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications; 9 month stability (manufacturer)

Which lots are affected?

Lot # 153855, exp 01/2017

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Amerisource Health Services

All 69

Other Candesartan Cilexetil recalls

All 11